GoHealth (NASDAQ:GOCO) Issues Earnings Results

GoHealth (NASDAQ:GOCO) announced its earnings results on Monday. The company reported ($2.36) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.40) by $0.04, FiscalAI reports. GoHealth had a negative return on equity of 33.29% and a negative net margin of 71.06%.The firm had revenue of $11.91 million during the quarter, compared to analysts’ expectations of $16.90 million.

GoHealth Trading Up 0.9%

GOCO opened at $0.86 on Tuesday. GoHealth has a 1-year low of $0.83 and a 1-year high of $7.12. The stock has a market capitalization of $24.88 million, a price-to-earnings ratio of -0.05 and a beta of 1.33. The business has a 50 day moving average of $1.30 and a 200-day moving average of $2.05.

Analysts Set New Price Targets

Several research firms have recently weighed in on GOCO. Freedom Capital cut GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of GoHealth in a research report on Friday, April 24th. Finally, Noble Financial raised GoHealth to a “strong-buy” rating in a research report on Wednesday, April 1st. One research analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $5.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Redwood Capital Management LLC bought a new position in GoHealth in the third quarter worth $4,455,000. Geode Capital Management LLC lifted its position in GoHealth by 8.1% in the fourth quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock worth $324,000 after purchasing an additional 11,340 shares during the period. Corient Private Wealth LLC lifted its position in GoHealth by 7.7% in the second quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock worth $699,000 after purchasing an additional 8,979 shares during the period. Barclays PLC lifted its position in GoHealth by 10.1% in the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after purchasing an additional 7,430 shares during the period. Finally, Focus Partners Wealth bought a new position in GoHealth in the third quarter worth $270,000. 24.21% of the stock is owned by institutional investors.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.